PARK CITY, Utah, Nov. 6, 2023 /PRNewswire/ -- BlueWind Medical, Ltd., a pioneer in the development and commercialization of a patient centric implantable Tibial NeuroModulation (iTNM) solution for ...
Neurolief announced today that the FDA granted approval for its Proliv Rx at-home neuromodulation therapy for treating ...
- This demonstration of a miniature implantable stimulator used in humans could unlock minimally invasive therapies for treatment-resistant neuropsychiatric disorders - Approximately 30% of adults ...
The US Food and Drug Administration (FDA) has granted 510 (k) clearance for BlueWind Medical, Ltd.’s enhanced Revi® implantable tibial neuromodulator for treatment of urgency urinary incontinence (UUI ...
As we enter 2026, there are two distinct technologies used by clinicians to interact with the brain: Brain-Computer ...
When most people consider treatment for psychiatric problems, they usually consider medications and/or psychotherapy. However, emerging neuromodulation approaches using transcranial magnetic ...
“We believe the new Category I CPT codes will enable more predictable and consistent reimbursement for Barostim patients and healthcare professionals,” said Kevin Hykes, President and Chief Executive ...
We expect free cash flow to improve through the year as the pandemic-driven delays in neuromodulation procedures ease. Cash flow growth should accelerate as we head into 2023. The firm does not pay a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback